CRISPR Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BRSE:1CG Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
19 Feb 25	SellCHF 254,084	Samarth Kulkarni	Individual		5,318	CHF 47.78

Insider Trading Volume

Insider Buying: 1CG insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1CG?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	374,024	0.436%
General Public	22,874,514	26.7%
Institutions	62,525,936	72.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 59.87% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.7%	Capital Research and Management Company	9,185,813	CHF 394.8m	9.98%	0.02%
10.5%	ARK Investment Management LLC	8,973,064	CHF 385.7m	19.7%	3.24%
4.47%	T. Rowe Price Group, Inc.	3,836,271	CHF 164.9m	38.9%	0.02%
3.22%	BlackRock, Inc.	2,759,326	CHF 118.6m	-1.29%	no data
3.2%	Nikko Asset Management Co., Ltd.	2,745,676	CHF 118.0m	-53.7%	0.05%
3.12%	UBS Asset Management AG	2,674,181	CHF 114.9m	98.1%	0.01%
2.9%	State Street Global Advisors, Inc.	2,491,525	CHF 107.1m	-16.8%	no data
2.59%	FMR LLC	2,223,262	CHF 95.6m	-6.43%	0.01%
2.02%	The Vanguard Group, Inc.	1,735,998	CHF 74.6m	0.61%	no data
1.85%	New Enterprise Associates, Inc.	1,587,854	CHF 68.2m	0%	4.05%
1.72%	Orbis Investment Management Limited	1,476,119	CHF 63.4m	0%	0.24%
1.62%	EcoR1 Capital, LLC	1,389,276	CHF 59.7m	0%	3.13%
1.52%	Baker Bros. Advisors LP	1,308,011	CHF 56.2m	55.2%	0.63%
1.22%	SR One Capital Management, LP	1,048,951	CHF 45.1m	0%	14.01%
1.17%	Geode Capital Management, LLC	1,000,868	CHF 43.0m	-0.73%	no data
1.1%	Dimensional Fund Advisors LP	947,301	CHF 40.7m	14.9%	0.01%
1.06%	Loomis Sayles & Company, L.P.	910,965	CHF 39.2m	-3.63%	0.06%
1.04%	Balyasny Asset Management L.P.	893,935	CHF 38.4m	43.3%	0.11%
1.02%	Citadel Advisors LLC	878,896	CHF 37.8m	69.5%	0.04%
0.84%	Charles Schwab Investment Management, Inc.	723,032	CHF 31.1m	-0.17%	0.01%
0.83%	Bank of America Corporation, Asset Management Arm	715,626	CHF 30.8m	41.9%	0.01%
0.58%	Versant Venture Management, LLC	498,558	CHF 21.4m	0%	11.49%
0.55%	Morgan Stanley, Investment Banking and Brokerage Investments	475,454	CHF 20.4m	-19.6%	no data
0.52%	Norges Bank Investment Management	443,536	CHF 19.1m	-31.8%	no data
0.5%	Jane Street Group, LLC, Asset Management Arm	426,817	CHF 18.3m	149%	0.03%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/22 14:51
End of Day Share Price	2025/02/19 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CRISPR Therapeutics AG is covered by 45 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jack Allen	Baird
Huidong Wang	Barclays
Konstantinos Biliouris	BMO Capital Markets Equity Research